Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
You can purchase shares of Organogenesis Hldgs (NASDAQ:ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Korro Bio (NASDAQ:KRRO) and Sangamo Therapeutics (NASDAQ:SGMO).
Organogenesis Hldgs has a consensus price target of $4.88.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $3.05 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Organogenesis Hldgs.
Organogenesis Hldgs’s Q4 earnings are confirmed for Thursday, February 27, 2025.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.